Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study by Joshua Aviram, Yelena Vysotski, Paula Berman, Gil M. Lewitus, Elon Eisenberg, David Meiri

“…Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this indication. …”
Get full text

Medical Cannabis Induced Acute Pancreatitis and Hyperemesis Syndrome in a Patient with Complex Regional Pain Syndrome by Cheryl Hutflesz, Vikas Parihar

“…Introduction: Medical cannabis is being utilized for intractable pain that is not well managed through conventional means. …”
Get full text

Knowledge, attitudes and beliefs about medical cannabis among the medical students of the Belarus State Medical University by Natallia Khamenka, Uladzimir Pikirenia

Subjects: Get full text

Innovative Clinical-Organizational Model to Ensure Appropriateness and Quality in the Management of Medical Cannabis: An Italian Regional Case by Eleonora Russo, Clara Cannas, Maria Susanna Rivetti, Carla Villa, Barbara Rebesco

Subjects: “…medical cannabis…”
Get full text

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review by Babasola O. Okusanya, Ibitola O. Asaolu, John E. Ehiri, Linda Jepkoech Kimaru, Abidemi Okechukwu, Cecilia Rosales

Subjects: Get full text

Characteristics for Medical Cannabis Treatment Adherence Among Autistic Children and Their Families: A Mixed-Methods Analysis by Ayelet David, Orit Stolar, Matitiahu Berkovitch, Elkana Kohn, Michal Waisman-Nitzan, Inbar Hartmann, Eynat Gal

“…Medical Cannabis and Cannabinoids…”
Get full text

Individuals’ Values and Preferences Regarding Medical Cannabis for Chronic Pain: A Descriptive Qualitative Study by Cummings H, Ul Haq MZ, Dargham A, Shakeel N, Busse JW, Darzi AJ, Alvarez E

Subjects: “…medical cannabis…”
Get full text

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey by Suraev A, Mills L, Abelev SV, Arkell TR, Lintzeris N, McGregor IS

Subjects: “…medical cannabis…”
Get full text

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis by Francesco Paolo Busardò, Ana Pilar Pérez-Acevedo, Roberta Pacifici, Giulio Mannocchi, Massimo Gottardi, Esther Papaseit, Clara Pérez-Mañá, Soraya Martin, Lourdes Poyatos, Simona Pichini, Magí Farré

Subjects: Get full text

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety by Orit Stolar, Ariela Hazan, Roni Enten Vissoker, Ibrahim Abu Kishk, Dana Barchel, Mirit Lezinger, Adi Dagan, Nir Treves, David Meiri, Matitiahu Berkovitch, Elkana Kohn, Eli Heyman

“…A comparison of the group with additional medications (n = 14) to those who received solely medical cannabis (n = 45) showed no difference in biochemical analysis, including liver enzymes, which remained stable, except for change in potassium level which was significantly higher in the group that did not receive additional medications (0.04 ± 0.37) compared to the group receiving concomitant drug therapy (-0.2 ± 0.33) (p = 0.04). …”
Get full text

Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board by Dillon Nussbaum, BS, Sapana Desai, MD, Adrianna Gonzalez-Lopez, MD, Jason E. Hawkes, MD, MS, George Gondo, MA, Adam Friedman, MD

Get full text

Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort by Meenu Minhas, Stephanie E. Lunn

“…Abstract Background The aim of the current study was to examine patterns of medical cannabis use in those using it to treat anxiety and to investigate if the anxiolytic effects of cannabis were impacted by gender and/or age. …”
Get full text

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis by Ana Pilar Pérez-Acevedo, Francesco Paolo Busardò, Roberta Pacifici, Giulio Mannocchi, Massimo Gottardi, Lourdes Poyatos, Esther Papaseit, Clara Pérez-Mañá, Soraya Martin, Annagiulia Di Trana, Simona Pichini, Magí Farré

Subjects: Get full text

Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients by Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri

Subjects: “…medical cannabis…”
Get full text

Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry by Simon Erridge, Jess Kerr-Gaffney, Carl Holvey, Ross Coomber, Daniela A. Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, Mikael H. Sodergren, James J. Rucker

“…Objective: This case series aims to assess changes to health-related quality of life and the incidence of adverse events in patients treated with CBMPs for associated symptoms of ASD enrolled on the UK Medical Cannabis Registry (UKMCR). Methods: Patients treated with CBMPs for ASD-related symptoms for a minimum of 1 month were identified from the UKMCR. …”
Get full text

A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance by Matthew Murphy, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren

Get full text

The association between cannabis and codeine use: a nationally representative cross-sectional study in Canada by Ria Garg, Kam Shojania, Mary A. De Vera

Subjects: “…Medical cannabis…”
Get full text

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process by Arun Bhaskar, Alan Bell, Michael Boivin, Wellington Briques, Matthew Brown, Hance Clarke, Claude Cyr, Elon Eisenberg, Ricardo Ferreira de Oliveira Silva, Eva Frohlich, Peter Georgius, Malcolm Hogg, Tina Ingrid Horsted, Caroline A. MacCallum, Kirsten R. Müller-Vahl, Colleen O’Connell, Robert Sealey, Marc Seibolt, Aaron Sihota, Brennan K. Smith, Dustin Sulak, Antonio Vigano, Dwight E. Moulin

Subjects: “…Medical cannabis…”
Get full text

UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder by Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren

“…Methods Patients were identified from the UK Medical Cannabis Registry. Primary outcomes were changes in the following patient‐reported outcome measures (PROMs) at 1, 3, 6, and 12 months from baseline: EQ‐5D‐5L index value, generalized anxiety disorder‐7 (GAD‐7) questionnaire, and the single‐item sleep quality score (SQS). …”
Get full text

Planting the seeds for success: A qualitative study exploring primary healthcare providers' perceptions about medical cannabis. by Sandi Schuhmacher, Dina Gaid, Lisa D Bishop, Laura Fleming, Jennifer Donnan

“…However, Canadians still struggle with finding healthcare professionals (HCPs) who are involved in medical cannabis counselling and authorization. This raises questions about the barriers that are causing this breakdown in care. …”
Get full text